T. Rowe Price Associates
HURA

T. Rowe Price Associates’s TuHURA Biosciences HURA Stock Holding History

T. Rowe Price Associates’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,128
Closed -$24K – 3352
2026
Q1 		$24K Hold
13,128
– – ﹤0.01% 3114
2025
Q4 		$10K Hold
13,128
– – ﹤0.01% 3086
2025
Q3 		$33K Hold
13,128
– – ﹤0.01% 3029
2025
Q2 		$30K Buy
+13,128
New +$44.4K ﹤0.01% 3038

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

T. Rowe Price Associates's HURA Position: Q2 2026 in Review

T. Rowe Price Associates sold out of TuHURA Biosciences (HURA) in Q2 2026, closing a stake of 13,128 shares — an estimated $24K sold.

T. Rowe Price Associates first reported a position in HURA in Q2 2025 and held it in 4 quarters. The position peaked at $33K in Q3 2025. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • T. Rowe Price Associates reported no remaining TuHURA Biosciences position as of Q2 2026 after selling out during the quarter.
  • T. Rowe Price Associates sold 13,128 TuHURA Biosciences shares in Q2 2026, an estimated $24K.
  • T. Rowe Price Associates first reported a position in TuHURA Biosciences in Q2 2025 and held it in 4 quarters.
  • T. Rowe Price Associates's TuHURA Biosciences position peaked at $33K in Q3 2025.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.